90 related articles for article (PubMed ID: 3135291)
1. Ex vivo activation of killer monocytes (AKM) and their application to the treatment of human cancer.
Stevenson HC; Lacerna LV; Sugarbaker PH
J Clin Apher; 1988; 4(2-3):118-21. PubMed ID: 3135291
[TBL] [Abstract][Full Text] [Related]
2. Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis.
Stevenson HC; Keenan AM; Woodhouse C; Ottow RT; Miller P; Steller EP; Foon KA; Abrams PG; Beman J; Larson SM
Cancer Res; 1987 Nov; 47(22):6100-3. PubMed ID: 3117363
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis.
Faradji A; Bohbot A; Frost H; Schmitt-Goguel M; Siffert JC; Dufour P; Eber M; Lallot C; Wiesel ML; Bergerat JP
J Clin Oncol; 1991 Jul; 9(7):1251-60. PubMed ID: 2045866
[TBL] [Abstract][Full Text] [Related]
4. Apheresis-elutriation program for adoptive immunotherapy with autologous activated monocytes in cancer patients.
Faradji A; Bohbot A; Schmitt-Goguel M; Dumont S; Eischen A; Wiesel ML; Stierle A; Follea G; Eber M; Bergerat JP
Int J Artif Organs; 1991 May; 14(5):304-12. PubMed ID: 1864656
[TBL] [Abstract][Full Text] [Related]
5. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
Weiner LM; Padavic-Shaller K; Kitson J; Watts P; Krigel RL; Litwin S
Cancer Res; 1991 Aug; 51(15):3910-8. PubMed ID: 1906779
[TBL] [Abstract][Full Text] [Related]
6. Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
Matsunaga H; Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1988 Oct; 23(5):527-33. PubMed ID: 3145895
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo activated monocytes and adoptive immunotherapy trials in colon cancer patients.
Stevenson HC; Foon KA; Sugarbaker PH
Prog Clin Biol Res; 1986; 211():75-82. PubMed ID: 3515364
[No Abstract] [Full Text] [Related]
8. The MHC influences NK and NKT cell functions associated with immune abnormalities and lifespan.
Dubey DP; Husain Z; Levitan E; Zurakowski D; Mirza N; Younes S; Coronell C; Yunis D; Yunis EJ
Mech Ageing Dev; 2000 Feb; 113(2):117-34. PubMed ID: 10708259
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma-induced alterations of monocyte susceptibility to lysis by autologous lymphokine-activated killer (LAK) cells.
Djeu JY; Blanchard DK
Int J Cancer; 1988 Sep; 42(3):449-54. PubMed ID: 3138195
[TBL] [Abstract][Full Text] [Related]
10. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
12. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
13. Adoptive cancer immunotherapy utilizing lymphokine activated killer cells and gamma interferon activated killer monocytes.
Lacerna LV; Stevenson GW; Stevenson HC
Pharmacol Ther; 1988; 38(3):453-65. PubMed ID: 3143128
[No Abstract] [Full Text] [Related]
14. CD4(+) T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes.
Yoneda T; Ellner JJ
Am J Respir Crit Care Med; 1998 Aug; 158(2):395-403. PubMed ID: 9700112
[TBL] [Abstract][Full Text] [Related]
15. A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes.
Andreesen R; Scheibenbogen C; Brugger W; Krause S; Leser HG; Kopf S; Engler H; Schümichen C; Löhr GW
Cancer Detect Prev; 1991; 15(5):413-21. PubMed ID: 1751953
[TBL] [Abstract][Full Text] [Related]
16. Modulation of in vitro antitumor immunity in response to the biological activators interleukin-2, gamma interferon, and granulocyte monocyte-colony stimulating factor in the peripheral blood of cancer patients receiving cytotoxic chemotherapy.
Harris JE; Braun DP
Bull N Y Acad Med; 1989 Jan; 65(1):16-25. PubMed ID: 2513993
[No Abstract] [Full Text] [Related]
17. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and B-cell Activating Factor (BAFF) promote bovine B cell activation independent of TLR9 and T-cell signaling.
Buchanan R; Popowych Y; Dagenais C; Arsic N; Mutwiri GK; Potter AA; Babiuk LA; Griebel PJ; Wilson HL
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):453-63. PubMed ID: 22264737
[TBL] [Abstract][Full Text] [Related]
19. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.
Carson WE; Ross ME; Baiocchi RA; Marien MJ; Boiani N; Grabstein K; Caligiuri MA
J Clin Invest; 1995 Dec; 96(6):2578-82. PubMed ID: 8675621
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells.
Walewski J; Paietta E; Dutcher J; Wiernik PH
J Cancer Res Clin Oncol; 1989; 115(2):170-4. PubMed ID: 2654134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
